Gain Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Gain Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
  • Gain Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.46M, a 8.72% increase year-over-year.
  • Gain Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$21.4M, a 4.38% increase year-over-year.
  • Gain Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$22.3M, a 25.2% decline from 2022.
  • Gain Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$17.8M, a 28.6% decline from 2021.
  • Gain Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$13.8M, a 297% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$21.4M -$4.46M +$426K +8.72% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$21.9M -$8.18M -$452K -5.84% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$21.4M -$4.38M +$852K +16.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$22.3M -$4.41M +$154K +3.38% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$22.4M -$4.89M -$134K -2.82% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$22.3M -$7.73M -$2.55M -49.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$19.7M -$5.23M -$1.94M -59% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$17.8M -$4.56M -$1.35M -42.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$16.4M -$4.75M -$115K -2.48% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$16.3M -$5.18M -$1.66M -47.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$14.6M -$3.29M -$822K -33.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$13.8M -$3.21M -$1.59M -98.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$12.2M -$4.64M -$3.82M -466% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$8.42M -$3.51M -$2.98M -560% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$5.43M -$2.47M -$1.95M -382% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$3.48M -$1.62M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$819K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$532K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$512K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.